Carnegie acted as joint bookrunner in the directed share issue of 9,100,548 million new shares. Cantargia is a biotechnology company that develops antibody-based treatments for life-threatening diseases. December 2020.
Healthcare
Directed share issue in Cantargia AB (SE) — SEK 564 million
December 2020